| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/29/2023 | — | B of A Securities | Upgrades | Neutral → Buy | |
| 07/20/2023 | 23.2% | Morgan Stanley | $64 → $68.5 | Upgrades | Equal-Weight → Overweight |
| 06/22/2023 | — | Deutsche Bank | Upgrades | Hold → Buy | |
| 06/08/2023 | 25.9% | Evercore ISI Group | $80 → $70 | Maintains | Outperform |
| 11/19/2021 | — | Redburn Partners | Upgrades | Neutral → Buy | |
| 09/30/2021 | — | Argus Research | Downgrades | Buy → Hold | |
| 09/02/2021 | 2.52% | JP Morgan | → $57 | Downgrades | Neutral → Underweight |
| 06/18/2021 | 58.27% | Argus Research | $65 → $88 | Maintains | Buy |
| 10/07/2020 | — | Jefferies | Upgrades | Hold → Buy | |
| 07/30/2020 | 34.89% | Evercore ISI Group | → $75 | Upgrades | In-Line → Outperform |
| 05/26/2020 | -10.07% | CFRA | $70 → $50 | Maintains | Hold |
| 05/20/2020 | -29.86% | JP Morgan | → $39 | Upgrades | Underweight → Neutral |
| 03/12/2020 | — | RBC Capital | Upgrades | Sector Perform → Outperform | |
| 03/09/2020 | — | Credit Suisse | Downgrades | Outperform → Neutral | |
| 03/03/2020 | — | B of A Securities | Downgrades | Buy → Neutral | |
| 02/28/2020 | — | Bryan Garnier | Downgrades | Buy → Neutral | |
| 02/26/2020 | — | Goldman Sachs | Initiates Coverage On | → Neutral | |
| 02/20/2020 | 16.91% | JP Morgan | $79 → $65 | Downgrades | Neutral → Underweight |
| 11/18/2019 | — | Redburn Partners | Upgrades | Sell → Neutral | |
| 11/07/2019 | 42.09% | JP Morgan | $94.5 → $79 | Maintains | Neutral |
| 08/27/2019 | — | Barclays | Downgrades | Equal-Weight → Underweight | |
| 08/06/2019 | — | UBS | Downgrades | Buy → Neutral | |
| 07/29/2019 | — | B of A Securities | Upgrades | Neutral → Buy | |
| 05/30/2019 | — | Argus Research | Upgrades | Hold → Buy | |
| 04/02/2019 | — | Barclays | Initiates Coverage On | → Equal-Weight | |
| 03/07/2019 | 34.89% | RBC Capital | → $75 | Downgrades | Top Pick → Sector Perform |
| 03/01/2019 | 51.08% | Macquarie | $80 → $84 | Maintains | Neutral |
| 01/22/2019 | — | RBC Capital | Upgrades | Outperform → Top Pick | |
| 01/16/2019 | — | Jefferies | Downgrades | Hold → Underperform | |
| 11/12/2018 | — | Argus Research | Downgrades | Buy → Hold | |
| 10/29/2018 | — | RBC Capital | Upgrades | Sector Perform → Outperform | |
| 10/01/2018 | — | Jefferies | Downgrades | Buy → Hold |
What is the target price for Anheuser-Busch InBev (BUD)?
The latest price target for Anheuser-Busch InBev (NYSE: BUD) was reported by B of A Securities on September 29, 2023. The analyst firm set a price target for $0.00 expecting BUD to fall to within 12 months (a possible -100.00% downside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Anheuser-Busch InBev (BUD)?
The latest analyst rating for Anheuser-Busch InBev (NYSE: BUD) was provided by B of A Securities, and Anheuser-Busch InBev upgraded their buy rating.
When is the next analyst rating going to be posted or updated for Anheuser-Busch InBev (BUD)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Anheuser-Busch InBev, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Anheuser-Busch InBev was filed on September 29, 2023 so you should expect the next rating to be made available sometime around September 29, 2024.
Is the Analyst Rating Anheuser-Busch InBev (BUD) correct?
While ratings are subjective and will change, the latest Anheuser-Busch InBev (BUD) rating was a upgraded with a price target of $0.00 to $0.00. The current price Anheuser-Busch InBev (BUD) is trading at is $55.60, which is out of the analyst's predicted range.